205 related articles for article (PubMed ID: 14997315)
21. Conflicting evidence surrounding the clopidogrel and proton pump inhibitor drug interaction.
Chua D; Shalansky SJ; Legal MG; Jung J
Arch Intern Med; 2010 Sep; 170(16):1507-8; author reply 1508. PubMed ID: 20837843
[No Abstract] [Full Text] [Related]
22. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
[TBL] [Abstract][Full Text] [Related]
23. Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods.
Smock KJ; Saunders PJ; Rodgers GM; Johari V
Am J Hematol; 2011 Dec; 86(12):1032-4. PubMed ID: 21812020
[TBL] [Abstract][Full Text] [Related]
24. Understanding and minimizing late thrombosis of drug-eluting stents.
Rabbat MG; Bavry AA; Bhatt DL; Ellis SG
Cleve Clin J Med; 2007 Feb; 74(2):129-36. PubMed ID: 17333640
[TBL] [Abstract][Full Text] [Related]
25. [Proton pump inhibitors: anti-ulcer agents or platelet aggregation inhibitors? Caution regarding drug interactions].
Ouellet J
Perspect Infirm; 2010; 7(3):40. PubMed ID: 21744587
[No Abstract] [Full Text] [Related]
26. A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel.
Floyd JS; Kaspera R; Marciante KD; Weiss NS; Heckbert SR; Lumley T; Wiggins KL; Tamraz B; Kwok PY; Totah RA; Psaty BM
Clin Pharmacol Ther; 2012 May; 91(5):896-904. PubMed ID: 22419147
[TBL] [Abstract][Full Text] [Related]
27. Clopidogrel-statin interaction: myth or reality?
Angiolillo DJ; Alfonso F
J Am Coll Cardiol; 2007 Jul; 50(4):296-8. PubMed ID: 17659195
[No Abstract] [Full Text] [Related]
28. [Individual pharmacotherapy safety in the assessment of cytochrome P-450 3A4 (CYP3A4) isoenzyme activity].
Sivkov AS; Paukov SV; Ruvinov IuV; Kukes IV
Klin Med (Mosk); 2010; 88(2):61-7. PubMed ID: 21105476
[TBL] [Abstract][Full Text] [Related]
29. Lipophilic statins do not affect the antiplatelet potency of clopidogrel.
Tselepis AD; Goudevenos JA
Platelets; 2005; 16(3-4):225-6. PubMed ID: 16011971
[TBL] [Abstract][Full Text] [Related]
30. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
[TBL] [Abstract][Full Text] [Related]
32. [Dilemma between gastroprotection and cardiovascular prevention].
Venerito M; Kandulski A; Malfertheiner P
Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006
[TBL] [Abstract][Full Text] [Related]
33. Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
Lansky AJ; Tsuchiya Y; Brener M; Mehran R; Cristea E; Pietras C; Grines CL; Cox DA; Garcia E; Tcheng JE; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Leon MB; Moses J; Stone GW
Catheter Cardiovasc Interv; 2008 Dec; 72(7):917-24. PubMed ID: 19016469
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin-clopidogrel interaction.
Martin PT; Denman R
Circulation; 2003 Jun; 107(24):e223; author reply e223. PubMed ID: 12821599
[No Abstract] [Full Text] [Related]
35. Thienopyridines and statins: assessing a potential drug-drug interaction.
Neubauer H; Mügge A
Curr Pharm Des; 2006; 12(10):1271-80. PubMed ID: 16611111
[TBL] [Abstract][Full Text] [Related]
36. Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome.
Mukherjee D; Kline-Rogers E; Fang J; Munir K; Eagle KA
Heart; 2005 Jan; 91(1):23-6. PubMed ID: 15604326
[TBL] [Abstract][Full Text] [Related]
37. Variability in response to clopidogrel: where is the threshold for 'low response'?
Dániel A; Pintér T; Horváth IG; Komócsi A
Eur Heart J; 2007 Feb; 28(4):515-6; author reply 516. PubMed ID: 17289747
[No Abstract] [Full Text] [Related]
38. Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance.
Hulot JS; Collet JP; Montalescot G
Curr Cardiol Rep; 2011 Oct; 13(5):451-8. PubMed ID: 21826477
[TBL] [Abstract][Full Text] [Related]
39. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
40. [Clinically relevant interaction between clopidogrel and proton pump inhibitors].
Alban S; Dingermann T; Griese N; Kämmerer W; Schubert-Zsilavecz M; Schulz M; Trenk D; Zagermann-Muncke P
Pharm Unserer Zeit; 2009; 38(4):370-1. PubMed ID: 19572357
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
